Nanjing Pharmacare Co., Ltd.
Nanjing Pharmacare Co., Ltd., often referred to as Nanjing Pharmacare, is a prominent player in the pharmaceutical industry, headquartered in CV. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, primarily focusing on generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence in Asia and expanding into international markets, Nanjing Pharmacare is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting them apart through rigorous quality control and adherence to international standards. Nanjing Pharmacare has achieved notable milestones, including certifications from global regulatory bodies, solidifying its market position as a trusted supplier in the pharmaceutical sector.
DitchCarbon Score
How does Nanjing Pharmacare Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nanjing Pharmacare Co., Ltd.'s score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nanjing Pharmacare Co., Ltd.'s reported carbon emissions
Nanjing Pharmacare Co., Ltd., headquartered in CV, currently does not have available carbon emissions data for the most recent year, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that Nanjing Pharmacare has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges documented, which suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Nanjing Pharmacare's future climate commitments and initiatives will be crucial for aligning with global climate goals and enhancing their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nanjing Pharmacare Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
